227 related articles for article (PubMed ID: 3624218)
1. Legal liability with psychotropic drug use: extrapyramidal syndromes and tardive dyskinesia.
Mills MJ; Eth S
J Clin Psychiatry; 1987 Sep; 48 Suppl():28-33. PubMed ID: 3624218
[TBL] [Abstract][Full Text] [Related]
2. Current status of institutionalized mental health patients' right to refuse psychotropic drugs.
Kemna DJ
J Leg Med; 1985 Mar; 6(1):107-38. PubMed ID: 2860193
[No Abstract] [Full Text] [Related]
3. Legal aspects of tardive dyskinesia.
Davis JM; Comaty J
Encephale; 1988 Sep; 14 Spec No():257-61. PubMed ID: 2905653
[TBL] [Abstract][Full Text] [Related]
4. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
Cancro R; Davis JM; Klawans H; Tancredi L
J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
[TBL] [Abstract][Full Text] [Related]
6. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic agents: a review.
Dilsaver SC
Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
[TBL] [Abstract][Full Text] [Related]
8. Liberty and tardive dyskinesia: informed consent to antipsychotic medication in the forensic psychiatric hospital.
Kleinman SB
J Forensic Sci; 1990 Sep; 35(5):1155-62. PubMed ID: 2230691
[TBL] [Abstract][Full Text] [Related]
9. Update on legal issues associated with tardive dyskinesia.
Slovenko R
J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331
[TBL] [Abstract][Full Text] [Related]
10. Psychotropic medications and informed consent: a review.
Frank B; Gupta S; McGlynn DJ
Ann Clin Psychiatry; 2008; 20(2):87-95. PubMed ID: 18568580
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia and informed consent: myths and realities.
Munetz MR; Roth LH; Cornes CL
Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
[No Abstract] [Full Text] [Related]
12. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
13. Responsibility and compensation for tardive dyskinesia.
Appelbaum PS; Schaffner K; Meisel A
Am J Psychiatry; 1985 Jul; 142(7):806-10. PubMed ID: 2861753
[TBL] [Abstract][Full Text] [Related]
14. Legal aspects of neuroleptic-induced movement disorders.
Wettstein RM
Leg Med; 1985; ():117-79. PubMed ID: 2872562
[No Abstract] [Full Text] [Related]
15. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
Dose M
Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
[TBL] [Abstract][Full Text] [Related]
16. This prescription may be hazardous to your health: who is accountable to the patient?
Walsh CB
J Clin Psychopharmacol; 1993 Feb; 13(1):68-70. PubMed ID: 8486819
[No Abstract] [Full Text] [Related]
17. Informed consent and tardive dyskinesia.
Wettstein RM
J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):65S-70S. PubMed ID: 3065366
[TBL] [Abstract][Full Text] [Related]
18. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
19. Micro-effects of language on risk perception in drug prescribing behavior.
Bursztajn HJ; Chanowitz B; Gutheil TG; Hamm RM
Bull Am Acad Psychiatry Law; 1992; 20(1):59-66. PubMed ID: 1349499
[TBL] [Abstract][Full Text] [Related]
20. Movement disorders with neuroleptic drug treatment.
Tarsy D
Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
